rDEN1delta30

BIOLOGICAL3 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

DengueDengue FeverDengue Hemorrhagic Fever

Phase 1

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy Adults

CompletedNCT00089908

National Institute of Allergy and Infectious Diseases (NIAID)Dengue Fever

Start: 2004-09-30End: 2005-11-30Updated: 2008-01-18

Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue Virus

CompletedNCT00458120

National Institute of Allergy and Infectious Diseases (NIAID)Dengue Hemorrhagic Fever

Start: 2007-03-31End: 2008-08-31Updated: 2010-12-14

Safety of and Immune Response of a 2-dose Regimen of rDEN1delta30 Dengue Virus Vaccine

CompletedNCT00473135

National Institute of Allergy and Infectious Diseases (NIAID)Dengue

Start: 2007-05-31Target: 60Updated: 2010-01-13